Abstract
Complementary medications and herbal medicine for weight loss have become very popular. We report a case of thyroid dysfunction following the ingestion of a kelp-containing marketed diet in a 45-year-old woman with no previous thyroid disease. Signs of hyperthyroidism occurred shortly after a kelp-containing diet. Hyperthyroidism lasted 2 months and was followed by an overt hypothyroidism. The thyroid scintiscan exhibited an extremely low uptake and colour-Doppler ultrasonography revealed multiple small areas of pulsatile flow. After 3 months of levothyroxine substitutive therapy, normal thyroid function was recovered after levothyroxine discontinuation. This clinical history is compatible with a case of iodine-induced thyrotoxicosis followed by prolonged block of the sodium–iodide symporter activity as a consequence of excessive iodine consumption from kelp. Consumers of marketed diets containing kelp or other iodine-rich ingredients should be advised of the risk to develop a thyroid dysfunction also in the absence of underlying thyroid disease.
Background
The rising obesity epidemic is a worldwide high priority public health issue. Less calories intake and more exercise are often insufficient to overweight and obese to achieve a satisfactory weight loss. Complementary and alternative medicine for weight loss has never been more popular. Although dietary supplements marketed for weight loss are available in pharmacies, health food stores and on the Internet, most of these products have not been proven effective and some are dangerous. We report a case of thyroid dysfunction due to the consumption of a kelp-containing marketed diet. Kelp is a type of seaweed known for its rich iodine content. In some individuals, the high iodine load can result in thyroid dysfunction. Hypothyroidism or hyperthyroidism can be either subclinical or overt, transient or sometimes persistent.1
Case presentation
A 45-years-old woman presented to the outpatient clinic for mild anterior neck pain. Her medical history and family history were unremarkable. Previous endocrine tests revealed thyroid hormones and thyroid-stimulating hormone (TSH) plasma levels within the normal range and absence of thyroid autoimmunity. A detailed medical history revealed that 1 month before, she self-treated to weight loss for a period of 10 days by a nutrition product (Starguo Menu, Beijing Green World Nutrition Health Products Co, Ltd, Beijing, China; box 1).
Box 1 Components of STARGUO MENU*.
Soy flour
Black beans
Shallot
Black sesame
Buckwheat flour
Skim milk powder
Barley sprouts
Cornmeal
Oatmeal
Chinese jujube
White beans
Lotus seeds
Mushroom (Lentinus edodes)
Almonds
Seaweed (kelp)
Salt
Ginger
Soya phospholipids
Calcium carbonate
*The daily dose was 60 g, containing about 1800 μg iodine.
Investigations
At our first observation, she was 62 kg, 155 cm tall (body mass index 27.5), with clinical signs of hyperthyroidism: regular pulse of 90 bpm, warm moist skin, trembling hands, anxiety and insomnia. Physical examination confirmed an enlarged thyroid, slightly painful at palpation. All haematological parameters and sedimentation rate were in the normal ranges. The hormonal profile was of overt hyperthyroidism, antithyroid peroxidase and antithyroglobulin antibodies were negative (table 1).
Table 1.
Hormonal and antibody profile following STARGUO discontinuation
| fT3 | fT4 | TSH | Tg-Ab | TPO-Ab | L-T4 | |
|---|---|---|---|---|---|---|
| Normal range (days) | 2–4 pg/mL | 0.93–1.7 ng/dL | 0.27–4.2 μUI/mL | <60 U/mL | <60 U/mL | |
| 20 | 4.87 | 1.59 | 0.05 | 15 | 20 | No |
| 40 | 6.59 | 2.15 | 0.005 | No | ||
| 70 | 1.19 | 0.47 | 9.11 | No | ||
| 90 | 0.30 | 0.50 | 64.00 | 18 | 40 | No |
| 103 | 2.73 | 0.87 | 16.71 | Yes | ||
| 160 | 2.93 | 0.97 | 1.70 | Yes | ||
| 220 | 2.90 | 0.98 | 3.74 | 25 | 38 | No |
L-T4, indicates whether the patient was treated with levothyroxine 1.2 μg/kg/day.
The patient refused to take medications. Twenty days later, signs of hyperthyroidism and biochemical hyperthyroidism were more evident. Ultrasonography revealed a slightly enlarged gland with heterogeneous pattern diffusely hypoechoic (figure 1A). Nodules were not present. By colour-Doppler the gland showed multiple small areas of pulsatile flow diffusely throughout the gland (thyroid inferno; figure 1B). One month later, the patient complained of cold intolerance, dry skin, sleepiness, weakness and depression. Hormonal profile was of overt hypothyroidism with absent thyroid antibodies. Ten days later the clinical symptoms persisted, colour-Doppler ultrasonography revealed a normal intrathyroidal blood-flow (figure 1B). 99 mTc thyroid scintiscan exhibited an extremely low uptake (figure 2). Urinary iodine was in the normal range (80 ng/L).
Figure 1.

Thyroid hormones and thyroid-stimulating harmone (TSH) profile. Hormones were measured after the indicated day from STARGUO discontinuation. The grey area indicates the treatment with L-4. Normal ranges: fT3, 2–4 pg/mL; fT4, 0.93–1.7 ng/dL; TSH, 0.27–4.2 μUI/mL.
Figure 2.
Thyroid ultrasonography and scintigraphy. B-mode and colour-Doppler ultrasonography 40 days (A, B) and 80 days (C, D) after STARGUO discontinuation.
Differential diagnosis
The modest thyroid pain at palpation could suggest the occurrence of a subacute thyroiditis. However, thyroid pain at palpation is compatible with the fast thyroid enlargement. The ultrasound feature of ‘thyroid inferno’ is not typical of subacute thyroiditis, while it has been documented to occur after an excessive iodine load.
Treatment
A substitutive therapy with oral levothyroxine (L-T4) at 1.2 μg/kg/day was initiated, followed by reliefs of all hypothyroid symptoms in 10 days. L-T4 therapy was discontinued after 80 days and thyroid status was revaluated.
Outcome and follow-up
Endocrine tests revealed thyroid hormones and TSH in the normal range and the absence of antithyroid antibodies.
Discussion
We describe a case of dysfunction following the ingestion of a marketed diet containing natural components, including kelp, a type of seaweed known for its rich iodine content and Lentinus edodes also known as ‘shiitake mushroom’ or ‘black forest mushroom’. Eritadenine, an adenosine analogue alkaloid isolated from L. edodes, has been shown to reduce cholesterol levels, whereas some polysaccharides present in this type of mycete, displayed some anti-inflammatory activity. These compounds do not have recognised effects on thyroid function.
Kelp is a type of seaweed known for its rich iodine content, available as a dietary supplement marketed for thyroid support. Iodine content in kelp varies depending on harvest location and preparation. Its average iodine content has been estimated to be about 1500 μg/g of dried preparation.2
The normal thyroid gland of human adults secretes about 50 μg iodine daily, an amount the gland can take up in a dietary iodine intake between 100 and 150 mg per day. Iodine excess may be tolerated or may induce thyroid disease with hypothyroidism or hyperthyroidism with or without goiter and autoimmunity. Most individuals with a normal thyroid gland tolerate large iodine excess, maintaining thyroid hormones within the normal range, although serum fT4 and fT3 can usually be moderately reduced, TSH increased and a small goiter can develop.3 4
The thyroid gland reacts to excess iodine intakes by different mechanisms the most important of which are the Wolff-Chaikoff effect, the down expression of the sodium–iodide symporter (NIS), and the block of hormone secretion from stores. The thyroid gland accumulates iodide from plasma against a concentration gradient up to 1:80. This iodide accumulation is made possible by the NIS that transports two sodium cations and one iodide anion across the basal cell membrane from the exterior into the interior of the cell.5 TSH strictly regulates NIS expression so that in iodine deficiency, TSH increases and in turn TSH gene expression is increased.6 In 1948, Wolff and Chaikoff reported that elevated plasma iodide levels was followed by a decreased organic binding of iodide in the thyroid.7 This effect (acute Wolff-Chaikoff effect) was of short duration and escape occurred in approximately 2 days, in the presence of continued high plasma iodide concentrations. The mechanism responsible for the acute Wolff-Chaikoff effect remains unknown and has been hypothesised to be caused by organic iodocompounds formed within the thyroid.8
Following the escape from the acute Wolff-Chaikoff effect, the biosynthesis of NIS can be shut down by a TSH-independent mechanism. Chronic excess iodide in rat FRTL-5 thyroid cells had no effect on NIS gene expression, whereas decreased NIS protein at a post-transcriptional level.9 In rats in vivo, excess iodide administration decreased both NIS mRNA and protein expression, by a mechanism that is at least in part, transcriptional.10 This mechanism has been proposed to account for the escape from the acute Wolff-Chaikoff effect. Excess iodine also blocks secretion of stored preformed hormone, as demonstrated in dog thyroid slices.11 Large quantity of iodide can also have cytotoxic effects as shown in normal human thyroid cells in vitro where it induces apoptosis, through a mechanism involving generation of free radicals.12 The normal thyroid gland adapts to iodine excess by these mechanisms so that most individuals tolerate a chronic excess of iodide without clinical symptoms.
Sometimes these mechanisms fail and iodine excess causes overt clinical hyperthyroidism or hypothyroidism. In some countries, iodine supplementation through iodised salt resulted in a significant number of cases of severe hyperthyroidism.13 14 Hyperthyroidism is most commonly encountered in regions of chronic iodine deficiency, in participants with long-standing nodular goiter and in hidden Graves’ disease or toxic adenoma silent because of iodine deficiency. Other sources of excessive iodine are iodinated radio-contrast material and the antiarrhythmic drug amiodarone.15–17 An other source of excessive iodine is dietary consumption of brown seaweed. Excessive iodine from kelp, a type of seaweed, has been described to adversely affect the thyroid.18 19 Kelp is available worldwide in grocery stores as it is a key ingredient of Japanese miso soup. It is also available as a dietary supplement in the form of capsules, powder and teas. Iodine-induced thyrotoxicosis has been reported after consuming a kelp-containing tea.20 In that case, the patient suffered from multinodular goiter in an endemic area of moderate iodine deficiency, that turned toxic after ingestion of the iodine-rich kelp and hyperthyroidism did not resolve spontaneously following discontinuation of the kelp-containing tea. The development of hypothyroidism with the negative metabolic effect of such a condition worsens the clinical situation of these participants. The reduced calories consumption, the reduction of psychic activities and the occurrence of depression, reduce the propensity of the participant to increase the exercise and determine the impossibility to obtain a weight loss even with an adequate reduction of calories intake. Failure to achieve a satisfactory weight loss may induce the hypothyroid participants to persist or even increase the consumption of the iodine-rich diet with the following worsening of the negative metabolic effects.
In our case, a participant with no evidence of pre-existing or underlying thyroid disease assumed for 10 days a daily dose of about 1800 μg iodine. Hyperthyroidism developed shortly, followed by overt hypothyroidism. In the acute hyperthyroid phase, the increased blood flow observed diffusely throughout the gland by colour Doppler ultrasonography, supports the occurrence of the Jod-Basedow phenomenon. The following hypothyroidism occurred about 2 months after diet discontinuation, was accompanied by inhibition of iodine uptake and normal urinary iodine secretion, suggesting a persistent downregulation of NIS. In general, escape from Wolff-Chaikoff effect is not achieved in patients with chronic systemic disease, euthyroid participants with Hashimoto's thyroiditis or Graves’ disease treated with metimazole or propyltiouracile, while it is controversial whether normal participants can develop hypothyroidism when exposed to large iodine doses.21 The case we describe demonstrates that also in participants with normal thyroid status, a persistent, not definitive hypothyroidism can be induced by iodine excess. This clinical case calls for keen attention to avoid herbal medicine or diets for weight loss, containing kelp or other iodine-rich ingredients also in participants with no evidence of thyroid disease.
Learning points.
Iodine excess can cause overt clinical hyperthyroidism or hypothyroidism in participants with hidden thyroid disease.
Also in participants with normal thyroid status, a persistent, not definitive hypothyroidism can be induced by iodine excess.
Herbal medicine or diets for weight loss containing kelp should be avoided also in participants with no evidence of thyroid disease.
Acknowledgments
This work has been supported in part by FARB funds of the University of Salerno (to M Vitale).
Footnotes
Competing interests: None.
Patient consent: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1.Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol 2014;10:136–42 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Teas J, Pino S, Critchley A, et al. Variability of iodine content in common commercially available edible seaweeds. Thyroid 2004;14:836–41 [DOI] [PubMed] [Google Scholar]
- 3.Philippou G, Koutras DA, Piperingos G, et al. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement. Clin Endocrinol (Oxf) 1992;36:573–8 [DOI] [PubMed] [Google Scholar]
- 4.Vagenakis AG, Downs P, Braverman LE, et al. Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest 1973;52:528–32 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dohan O, De la Vieja A, Paroder V, et al. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 2003;24:48–77 [DOI] [PubMed] [Google Scholar]
- 6.Kogai T, Endo T, Saito T, et al. Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 1997;138:2227–32 [DOI] [PubMed] [Google Scholar]
- 7.Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 1948;174:555–64 [PubMed] [Google Scholar]
- 8.Dugrillon A. Iodolactones and iodoaldehydes—mediators of iodine in thyroid autoregulation. Exp Clin Endocrinol Diabetes 1996;104(Suppl 4):41–5 [DOI] [PubMed] [Google Scholar]
- 9.Eng PH, Cardona GR, Previti MC, et al. Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 2001;144:139–44 [DOI] [PubMed] [Google Scholar]
- 10.Eng PH, Cardona GR, Fang SL, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 1999;140:3404–10 [DOI] [PubMed] [Google Scholar]
- 11.Van Sande J, Grenier G, Willems C, et al. Inhibition by iodide of the activation of the thyroid cyclic 3’,5’-AMP system. Endocrinology 1975;96:781–6 [DOI] [PubMed] [Google Scholar]
- 12.Vitale M, Di Matola T, D'Ascoli F, et al. Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology 2000;141:598–605 [DOI] [PubMed] [Google Scholar]
- 13.Bourdoux PP, Ermans AM, Mukalay wa Mukalay A, et al. Iodine-induced thyrotoxicosis in Kivu, Zaire. Lancet 1996;347:552–3 [DOI] [PubMed] [Google Scholar]
- 14.Stanbury JB, Ermans AE, Bourdoux P, et al. Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 1998;8:83–100 [DOI] [PubMed] [Google Scholar]
- 15.Martin FI, Tress BW, Colman PG, et al. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. Am J Med 1993;95:78–82 [DOI] [PubMed] [Google Scholar]
- 16.Tavackoli S, Stouffer GA, Sheahan RG. Amiodarone-induced thyrotoxicosis. Am J Med Sci 1997;314:97–100 [DOI] [PubMed] [Google Scholar]
- 17.Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984;101:28–34 [DOI] [PubMed] [Google Scholar]
- 18.Hartman AA. [Hyperthyroidism during administration of kelp tablets]. Nederlands tijdschrift voor geneeskunde 1990;134:1373. [PubMed] [Google Scholar]
- 19.Eliason BC. Transient hyperthyroidism in a patient taking dietary supplements containing kelp. J Am Board Fam Pract 1998;11:478–80 [DOI] [PubMed] [Google Scholar]
- 20.Mussig K, Thamer C, Bares R, et al. Iodine-induced thyrotoxicosis after ingestion of kelp-containing tea. J Gen Intern Med 2006;21:C11–14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Di Matola T, D'Ascoli F, Fenzi G, et al. Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism. J Clin Endocrinol Metab 2000;85:4323–30 [DOI] [PubMed] [Google Scholar]

